AI medicine and novel drug target discovery

 

At this unique virtual meeting the Milner Institute will bring together scientists from academia and industry in the UK and Korea.

 

The online workshop will consist of sessions highlighting new stories in AI medicine and drug discovery, along with panel discussions and interactive networking.

 

Dr Juergen Harter, CEO of CCDC, is delivering a presentation at 09:35am GMT on Tuesday 23rd February

Smart and trusted data enabling AI in digital drug discovery and development

 

Register and find out more on the organisers eventbrite page here.